CPN || Conferences

Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial

Posted on: 16/07/2014 - 21:45

COPENHAGEN – Once more, an antiamyloid antibody has failed to live up to hopes for the treatment of Alzheimer’s disease. Roche’s contender, crenezumab, faltered on all of the primary...

Field of Interest: Geriatrics

Type: News Item

Alzheimer’s may be declining in U.S. and Germany

Posted on: 15/07/2014 - 22:00

COPENHAGEN – The incidence of Alzheimer’s disease appears to be declining in the United States and may be following a similar positive trend in Germany as well. An analysis of the ongoing Framingham...

Field of Interest: Geriatrics

Type: News Item

Rising projection of Alzheimer’s cases stems mainly from better reporting

Posted on: 15/07/2014 - 18:55

COPENHAGEN – Researchers appear to be tracking contradictory trends in the global incidence and prevalence of Alzheimer’s disease. There’s no doubt that both are declining in the United...

Field of Interest: Geriatrics

Type: News Item

Smelling test makes progress in identifying preclinical Alzheimer’s

Posted on: 14/07/2014 - 18:20

COPENHAGEN – A test that measures how well patients recognize scents was highly correlated with progression from mild cognitive impairment to Alzheimer’s disease as well as neurodegeneration...

Field of Interest: Geriatrics

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial

Alzheimer’s may be declining in U.S. and Germany

Rising projection of Alzheimer’s cases stems mainly from better reporting

Smelling test makes progress in identifying preclinical Alzheimer’s

Newsletters

Latest Newsletters